Agree. This also doesnt seem to be up their alley in terms of experience. They seem to specialize more in small-molecule drugs. Although in spring 2010, they announced their move into biosimilars etc. Based in the Netherlands, not sure if they have any IP though here in the US; I will take a peak into this.
Market Data 
Markets 
AI
